| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-19 | 2009-09-30 | 13F-HR | Advent Capital Management | Institution | | Sold All | -5,000 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Advent Capital Management Ownership Of Human Genome Sciences Inc |
| 2009-11-19 | 2009-09-30 | 13F-HR/A | Royal Bank Of Canada | Institution | 517 | New Holding | 517 | 100 % | $14,073 | $14,073 | $0 | 0.00 % | $0 | | | | | | News Article | History of Royal Bank Of Canada Ownership Of Human Genome Sciences Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Institutional Funds Inc - Small Cap Growth Fund | Small-Cap Growth | 1,103 | No Compare | | | $30,708 | $30,024 | $-684 | -2.22 % | | | | | | | News Article | History of Mutual Of America Institutional Funds Inc - Small Cap Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Investment Corp - Small Cap Growth Fund | Small-Cap Growth | 56,936 | No Compare | | | $1,585,098 | $1,549,798 | $-35,300 | -2.22 % | | | | | | | News Article | History of Mutual Of America Investment Corp - Small Cap Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Timber Hill Llc | No Data | 104,483 | New Holding | 104,483 | 100 % | $2,908,807 | $2,844,027 | $-64,779 | -2.22 % | $-64,779 | | | | | | News Article | History of Timber Hill Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 272,496 | Sold Some | -1,382,780 | -83.53 % | $7,836,985 | $7,417,341 | $-419,644 | -5.35 % | $2,129,481 | | | | | | News Article | History of Amvescap Plc Ownership Of Human Genome Sciences Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Castleark Management Llc | Institution | 80,500 | New Holding | 80,500 | 100 % | $2,315,180 | $2,191,210 | $-123,970 | -5.35 % | $-123,970 | | | | | | News Article | History of Castleark Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 74,514 | Sold Some | -106,670 | -58.87 % | $2,143,023 | $2,028,271 | $-114,752 | -5.35 % | $164,272 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Human Genome Sciences Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Janus Capital Management Llc | Institution | 821,202 | Sold Some | -1,036,075 | -55.78 % | $23,617,770 | $22,353,118 | $-1,264,651 | -5.35 % | $1,595,556 | | | | | | News Article | History of Janus Capital Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 145,656 | Added More | 128,187 | 733.79 % | $4,189,067 | $3,964,756 | $-224,310 | -5.35 % | $-197,408 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ah Lisanti Capital Growth Llc | Institution | 97,580 | New Holding | 97,580 | 100 % | $2,826,893 | $2,656,128 | $-170,765 | -6.04 % | $-170,765 | | | | | | News Article | History of Ah Lisanti Capital Growth Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Alger Fred Management Inc | Institution | 4,399,201 | New Holding | 4,399,201 | 100 % | $127,444,853 | $119,746,251 | $-7,698,602 | -6.04 % | $-7,698,602 | | | | | | News Article | History of Alger Fred Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Altrinsic Global Advisors Llc | Institution | 250,000 | Sold Some | -25,000 | -9.09 % | $7,242,500 | $6,805,000 | $-437,500 | -6.04 % | $43,750 | | | | | | News Article | History of Altrinsic Global Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 191,029 | Added More | 81,084 | 73.74 % | $5,534,110 | $5,199,809 | $-334,301 | -6.04 % | $-141,897 | | | | | | News Article | History of American International Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Balyasny Asset Management Llc | Institution | 380,000 | New Holding | 380,000 | 100 % | $11,008,600 | $10,343,600 | $-665,000 | -6.04 % | $-665,000 | | | | | | News Article | History of Balyasny Asset Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bellman Walter Capital Llc | No Data | 55,000 | New Holding | 55,000 | 100 % | $1,593,350 | $1,497,100 | $-96,250 | -6.04 % | $-96,250 | | | | | | News Article | History of Bellman Walter Capital Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Black River Asset Management Llc | Institution | 6,600 | New Holding | 6,600 | 100 % | $191,202 | $179,652 | $-11,550 | -6.04 % | $-11,550 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital World Investors | Institution | 10,435,000 | New Holding | 10,435,000 | 100 % | $302,301,950 | $284,040,700 | $-18,261,250 | -6.04 % | $-18,261,250 | | | | | | News Article | History of Capital World Investors Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Charter Oak Partners | Institution | 1,217,100 | Sold Some | -382,900 | -23.93 % | $35,259,387 | $33,129,462 | $-2,129,925 | -6.04 % | $670,075 | | | | | | News Article | History of Charter Oak Partners Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 955,731 | New Holding | 955,731 | 100 % | $27,687,527 | $26,014,998 | $-1,672,529 | -6.04 % | $-1,672,529 | | | | | | News Article | History of Citadel L P Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cr Intrinsic Investors Llc | Institution | 250,000 | New Holding | 250,000 | 100 % | $7,242,500 | $6,805,000 | $-437,500 | -6.04 % | $-437,500 | | | | | | News Article | History of Cr Intrinsic Investors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Driehaus Capital Management Llc | Institution | 138,309 | New Holding | 138,309 | 100 % | $4,006,812 | $3,764,771 | $-242,041 | -6.04 % | $-242,041 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fidelity International Ltd | Institution | 26,100 | Added More | 14,390 | 122.88 % | $756,117 | $710,442 | $-45,675 | -6.04 % | $-25,183 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 10,000 | New Holding | 10,000 | 100 % | $289,700 | $272,200 | $-17,500 | -6.04 % | $-17,500 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 24,386,915 | Added More | 18,670,118 | 326.58 % | $706,488,928 | $663,811,826 | $-42,677,101 | -6.04 % | $-32,672,707 | | | | | | News Article | History of Fmr Corp Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | 696,950 | New Holding | 696,950 | 100 % | $20,190,642 | $18,970,979 | $-1,219,663 | -6.04 % | $-1,219,663 | | | | | | News Article | History of Galleon Management L P Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Gam Usa Inc | Institution | 126,600 | Sold Some | -74,400 | -37.01 % | $3,667,602 | $3,446,052 | $-221,550 | -6.04 % | $130,200 | | | | | | News Article | History of Gam Usa Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Gardner Lewis Asset Management L P | Institution | 63,435 | New Holding | 63,435 | 100 % | $1,837,712 | $1,726,701 | $-111,011 | -6.04 % | $-111,011 | | | | | | News Article | History of Gardner Lewis Asset Management L P Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 402,192 | Sold Some | -262,056 | -39.45 % | $11,651,502 | $10,947,666 | $-703,836 | -6.04 % | $458,598 | | | | | | News Article | History of Ing Groep Nv Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Jesaga Advisers Llc | Institution | 90,900 | New Holding | 90,900 | 100 % | $2,633,373 | $2,474,298 | $-159,075 | -6.04 % | $-159,075 | | | | | | News Article | History of Jesaga Advisers Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Mackenzie Financial Corp | Institution | 10,000 | New Holding | 10,000 | 100 % | $289,700 | $272,200 | $-17,500 | -6.04 % | $-17,500 | | | | | | News Article | History of Mackenzie Financial Corp Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Mazama Capital Management Inc | Institution | 181,930 | New Holding | 181,930 | 100 % | $5,270,512 | $4,952,135 | $-318,378 | -6.04 % | $-318,378 | | | | | | News Article | History of Mazama Capital Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | | Sold All | -25,000 | -100 % | | | | -6.04 % | $43,750 | | | | | | News Article | History of Millennium Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 1,472,107 | Added More | 694,561 | 89.32 % | $42,646,940 | $40,070,753 | $-2,576,187 | -6.04 % | $-1,215,482 | | | | | | News Article | History of Morgan Stanley Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 1,997,393 | Added More | 481,167 | 31.73 % | $57,864,475 | $54,369,037 | $-3,495,438 | -6.04 % | $-842,042 | | | | | | News Article | History of Northern Trust Corp Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Oberweis Asset Management Inc | Institution | 461,907 | Sold Some | -390,093 | -45.78 % | $13,381,446 | $12,573,109 | $-808,337 | -6.04 % | $682,663 | | | | | | News Article | History of Oberweis Asset Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 299,489 | Sold Some | -1,662,047 | -84.73 % | $8,676,196 | $8,152,091 | $-524,106 | -6.04 % | $2,908,582 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Pequot Capital Management Inc | Institution | | Sold All | -1,117,500 | -100 % | | | | -6.04 % | $1,955,625 | | | | | | News Article | History of Pequot Capital Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | 130,000 | Sold Some | -2,920,000 | -95.73 % | $3,766,100 | $3,538,600 | $-227,500 | -6.04 % | $5,110,000 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Principled Asset Administration Llc | Institution | 190,800 | New Holding | 190,800 | 100 % | $5,527,476 | $5,193,576 | $-333,900 | -6.04 % | $-333,900 | | | | | | News Article | History of Principled Asset Administration Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Quantlab Capital Management Ltd | Institution | 13,700 | New Holding | 13,700 | 100 % | $396,889 | $372,914 | $-23,975 | -6.04 % | $-23,975 | | | | | | News Article | History of Quantlab Capital Management Ltd Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rbc Dominion Securities Inc | Institution | 26,775 | Added More | 25,775 | 2577.50 % | $775,672 | $728,816 | $-46,856 | -6.04 % | $-45,106 | | | | | | News Article | History of Rbc Dominion Securities Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 433,346 | New Holding | 433,346 | 100 % | $12,554,034 | $11,795,678 | $-758,356 | -6.04 % | $-758,356 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 110,963 | Added More | 78,663 | 243.53 % | $3,214,598 | $3,020,413 | $-194,185 | -6.04 % | $-137,660 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Transamerica Investment Management Llc | Institution | 515,400 | New Holding | 515,400 | 100 % | $14,931,138 | $14,029,188 | $-901,950 | -6.04 % | $-901,950 | | | | | | News Article | History of Transamerica Investment Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Tryphon Capital Advisers Inc | Institution | 100,000 | New Holding | 100,000 | 100 % | $2,897,000 | $2,722,000 | $-175,000 | -6.04 % | $-175,000 | | | | | | News Article | History of Tryphon Capital Advisers Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 530,700 | Sold Some | -640,900 | -54.70 % | $15,374,379 | $14,445,654 | $-928,725 | -6.04 % | $1,121,575 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 188,733 | Added More | 178,799 | 1799.86 % | $5,467,595 | $5,137,312 | $-330,283 | -6.04 % | $-312,898 | | | | | | News Article | History of Us Bancorp De Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Walleye Trading Llc | Institution | 20,087 | New Holding | 20,087 | 100 % | $581,920 | $546,768 | $-35,152 | -6.04 % | $-35,152 | | | | | | News Article | History of Walleye Trading Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weintraub Capital Management Lp | Institution | 50,000 | New Holding | 50,000 | 100 % | $1,448,500 | $1,361,000 | $-87,500 | -6.04 % | $-87,500 | | | | | | News Article | History of Weintraub Capital Management Lp Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-11-13 | 13F-HR | Rodney Square Management Corp | Institution | 13,620 | New Holding | 13,620 | 100 % | $379,862 | $370,736 | $-9,125 | -2.40 % | $-9,125 | | | | | | News Article | History of Rodney Square Management Corp Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 200 | Sold Some | -29,300 | -99.32 % | $5,578 | $5,444 | $-134 | -2.40 % | $19,631 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 2,148,988 | Added More | 1,788,553 | 496.22 % | $59,935,275 | $58,495,453 | $-1,439,822 | -2.40 % | $-1,198,331 | | | | | | News Article | History of Axa Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 962,338 | Added More | 770,752 | 402.30 % | $26,839,607 | $26,194,840 | $-644,766 | -2.40 % | $-516,404 | | | | | | News Article | History of Barclays Plc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bartlett And Co | Institution | 900 | No Change | 0 | 0 % | $25,101 | $24,498 | $-603 | -2.40 % | $0 | | | | | | News Article | History of Bartlett And Co Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Batterymarch Financial Management Inc | Institution | 960,197 | Sold Some | -191,592 | -16.63 % | $26,779,894 | $26,136,562 | $-643,332 | -2.40 % | $128,367 | | | | | | News Article | History of Batterymarch Financial Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 65,083 | Added More | 53,720 | 472.76 % | $1,815,165 | $1,771,559 | $-43,606 | -2.40 % | $-35,992 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital One Financial Corp | Institution | 272 | New Holding | 272 | 100 % | $7,586 | $7,404 | $-182 | -2.40 % | $-182 | | | | | | News Article | History of Capital One Financial Corp Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | | Sold All | -157,343 | -100 % | | | | -2.40 % | $105,420 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Clearbridge Advisors Llc | Institution | 152 | New Holding | 152 | 100 % | $4,239 | $4,137 | $-102 | -2.40 % | $-102 | | | | | | News Article | History of Clearbridge Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 11,970 | New Holding | 11,970 | 100 % | $333,843 | $325,823 | $-8,020 | -2.40 % | $-8,020 | | | | | | News Article | History of Credit Agricole S A Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 191,000 | No Change | 0 | 0 % | $5,326,990 | $5,199,020 | $-127,970 | -2.40 % | $0 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Delaware Management Business Trust | Institution | 669,950 | New Holding | 669,950 | 100 % | $18,684,906 | $18,236,039 | $-448,867 | -2.40 % | $-448,867 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Denver Investment Advisors Llc | Institution | 1,267,185 | New Holding | 1,267,185 | 100 % | $35,341,790 | $34,492,776 | $-849,014 | -2.40 % | $-849,014 | | | | | | News Article | History of Denver Investment Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Diamondback Capital Management Llc | Institution | 133,695 | Sold Some | -834,631 | -86.19 % | $3,728,754 | $3,639,178 | $-89,576 | -2.40 % | $559,203 | | | | | | News Article | History of Diamondback Capital Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dixon Hubard And Feinour Inc | Institution | 11,560 | New Holding | 11,560 | 100 % | $322,408 | $314,663 | $-7,745 | -2.40 % | $-7,745 | | | | | | News Article | History of Dixon Hubard And Feinour Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Mercantile Trust Co | Institution | 20,257 | New Holding | 20,257 | 100 % | $564,968 | $551,396 | $-13,572 | -2.40 % | $-13,572 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Fortaleza Asset Management Inc | Institution | 73,700 | New Holding | 73,700 | 100 % | $2,055,493 | $2,006,114 | $-49,379 | -2.40 % | $-49,379 | | | | | | News Article | History of Fortaleza Asset Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 4,561 | Sold Some | -99,782 | -95.62 % | $127,206 | $124,150 | $-3,056 | -2.40 % | $66,854 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geduld E E | Institution | 35,000 | New Holding | 35,000 | 100 % | $976,150 | $952,700 | $-23,450 | -2.40 % | $-23,450 | | | | | | News Article | History of Geduld E E Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 379,100 | Added More | 54,924 | 16.94 % | $10,573,099 | $10,319,102 | $-253,997 | -2.40 % | $-36,799 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 459,713 | Added More | 2,762 | 0.60 % | $12,821,396 | $12,513,388 | $-308,008 | -2.40 % | $-1,851 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Grantham Mayo Van Otterloo And Co Llc | Institution | | Sold All | -10,100 | -100 % | | | | -2.40 % | $6,767 | | | | | | News Article | History of Grantham Mayo Van Otterloo And Co Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hbk Investments L P | Institution | 18,419 | New Holding | 18,419 | 100 % | $513,706 | $501,365 | $-12,341 | -2.40 % | $-12,341 | | | | | | News Article | History of Hbk Investments L P Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Independence Capital Asset Partners Llc | Institution | 370,000 | New Holding | 370,000 | 100 % | $10,319,300 | $10,071,400 | $-247,900 | -2.40 % | $-247,900 | | | | | | News Article | History of Independence Capital Asset Partners Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jefferies Group Inc | Institution | 115,357 | New Holding | 115,357 | 100 % | $3,217,307 | $3,140,018 | $-77,289 | -2.40 % | $-77,289 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jennison Associates Llc | Institution | 500,000 | New Holding | 500,000 | 100 % | $13,945,000 | $13,610,000 | $-335,000 | -2.40 % | $-335,000 | | | | | | News Article | History of Jennison Associates Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | 14,963 | Added More | 1,369 | 10.07 % | $417,318 | $407,293 | $-10,025 | -2.40 % | $-917 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Labranche And Co Inc | Institution | | Sold All | -178,914 | -100 % | | | | -2.40 % | $119,872 | | | | | | News Article | History of Labranche And Co Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Capital Management Inc | Institution | 1,576,303 | New Holding | 1,576,303 | 100 % | $43,963,091 | $42,906,968 | $-1,056,123 | -2.40 % | $-1,056,123 | | | | | | News Article | History of Legg Mason Capital Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Lmm Llc Md | Institution | 497,700 | New Holding | 497,700 | 100 % | $13,880,853 | $13,547,394 | $-333,459 | -2.40 % | $-333,459 | | | | | | News Article | History of Lmm Llc Md Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Lord Abbett And Co Llc | Institution | 503,385 | New Holding | 503,385 | 100 % | $14,039,408 | $13,702,140 | $-337,268 | -2.40 % | $-337,268 | | | | | | News Article | History of Lord Abbett And Co Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Los Angeles Capital Management And Equity Research Inc | Institution | 39,105 | New Holding | 39,105 | 100 % | $1,090,638 | $1,064,438 | $-26,200 | -2.40 % | $-26,200 | | | | | | News Article | History of Los Angeles Capital Management And Equity Research Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | 208,888 | Added More | 208,687 | 103824.37 % | $5,825,886 | $5,685,931 | $-139,955 | -2.40 % | $-139,820 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | 25,200 | New Holding | 25,200 | 100 % | $702,828 | $685,944 | $-16,884 | -2.40 % | $-16,884 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Lazard Mid Cap Portfolio | Mid-Cap Core | 375,000 | Added More | 19,000 | 5.33 % | $10,458,750 | $10,207,500 | $-251,250 | -2.40 % | $-12,730 | | | | | | News Article | History of Met Investors Series Trust - Lazard Mid Cap Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Neuberger Berman Group Llc | No Data | 867,650 | New Holding | 867,650 | 100 % | $24,198,759 | $23,617,433 | $-581,326 | -2.40 % | $-581,326 | | | | | | News Article | History of Neuberger Berman Group Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 86,670 | Sold Some | -230,830 | -72.70 % | $2,417,226 | $2,359,157 | $-58,069 | -2.40 % | $154,656 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oppenheimer And Co Inc | Institution | | Sold All | -65,836 | -100 % | | | | -2.40 % | $44,110 | | | | | | News Article | History of Oppenheimer And Co Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 53,797 | Sold Some | -4,768 | -8.14 % | $1,500,398 | $1,464,354 | $-36,044 | -2.40 % | $3,195 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 9,637,380 | Added More | 1,990,932 | 26.03 % | $268,786,528 | $262,329,484 | $-6,457,045 | -2.40 % | $-1,333,924 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | | Sold All | -4 | -100 % | | | | -2.40 % | $3 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 42,828 | Added More | 33,376 | 353.11 % | $1,194,473 | $1,165,778 | $-28,695 | -2.40 % | $-22,362 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Private Counsel Usa Inc | Institution | 1,200 | Added More | 200 | 20.00 % | $33,468 | $32,664 | $-804 | -2.40 % | $-134 | | | | | | News Article | History of Rbc Private Counsel Usa Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | | Sold All | -42,700 | -100 % | | | | -2.40 % | $28,609 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sei Trust Co | Institution | 56,110 | New Holding | 56,110 | 100 % | $1,564,908 | $1,527,314 | $-37,594 | -2.40 % | $-37,594 | | | | | | News Article | History of Sei Trust Co Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | 158,397 | Added More | 140,679 | 793.98 % | $4,417,692 | $4,311,566 | $-106,126 | -2.40 % | $-94,255 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Spark Lp | Institution | 46,300 | Sold Some | -189,100 | -80.33 % | $1,291,307 | $1,260,286 | $-31,021 | -2.40 % | $126,697 | | | | | | News Article | History of Spark Lp Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sprott Asset Management Inc | Institution | 80,000 | New Holding | 80,000 | 100 % | $2,231,200 | $2,177,600 | $-53,600 | -2.40 % | $-53,600 | | | | | | News Article | History of Sprott Asset Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 7,009,717 | Added More | 1,007,502 | 16.78 % | $195,501,007 | $190,804,497 | $-4,696,510 | -2.40 % | $-675,026 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | 164,800 | Added More | 48,300 | 41.45 % | $4,563,312 | $4,485,856 | $-77,456 | -1.69 % | $-22,701 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | 370,800 | New Holding | 370,800 | 100 % | $10,267,452 | $10,093,176 | $-174,276 | -1.69 % | $-174,276 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Baldwin Brothers Inc | Institution | | Sold All | -10,500 | -100 % | | | | -1.69 % | $4,935 | | | | | | News Article | History of Baldwin Brothers Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 659,286 | Added More | 574,553 | 678.07 % | $18,255,629 | $17,945,765 | $-309,864 | -1.69 % | $-270,040 | | | | | | News Article | History of Bank Of America Corp Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 8,665,803 | Added More | 1,458,700 | 20.23 % | $239,956,085 | $235,883,158 | $-4,072,927 | -1.69 % | $-685,589 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 8,665,803 | Added More | 1,119,350 | 14.83 % | $239,956,085 | $235,883,158 | $-4,072,927 | -1.69 % | $-526,095 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bennett Lawrence Management L L C | Institution | 421,475 | New Holding | 421,475 | 100 % | $11,670,643 | $11,472,550 | $-198,093 | -1.69 % | $-198,093 | | | | | | News Article | History of Bennett Lawrence Management L L C Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Calamos Advisors Llc | Institution | 1,412,000 | New Holding | 1,412,000 | 100 % | $39,098,280 | $38,434,640 | $-663,640 | -1.69 % | $-663,640 | | | | | | News Article | History of Calamos Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Charles Schwab Trust Company A Division Of Charles Schwab B | No Data | 28,300 | New Holding | 28,300 | 100 % | $783,627 | $770,326 | $-13,301 | -1.69 % | $-13,301 | | | | | | News Article | History of Charles Schwab Trust Company A Division Of Charles Schwab B Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chicago Equity Partners Llc | Institution | 45,200 | New Holding | 45,200 | 100 % | $1,251,588 | $1,230,344 | $-21,244 | -1.69 % | $-21,244 | | | | | | News Article | History of Chicago Equity Partners Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Columbia Wanger Asset Management Lp | Institution | 4,176,150 | New Holding | 4,176,150 | 100 % | $115,637,594 | $113,674,803 | $-1,962,791 | -1.69 % | $-1,962,791 | | | | | | News Article | History of Columbia Wanger Asset Management Lp Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 41,299 | New Holding | 41,299 | 100 % | $1,143,569 | $1,124,159 | $-19,411 | -1.69 % | $-19,411 | | | | | | News Article | History of Credit Suisse Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Trust Advisors Lp | Institution | 716,617 | Sold Some | -1,152,317 | -61.65 % | $19,843,125 | $19,506,315 | $-336,810 | -1.69 % | $541,589 | | | | | | News Article | History of First Trust Advisors Lp Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Hillsdale Investment Management Inc | Institution | | Sold All | -39,500 | -100 % | | | | -1.69 % | $18,565 | | | | | | News Article | History of Hillsdale Investment Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 427,196 | Sold Some | -314,404 | -42.39 % | $11,829,057 | $11,628,275 | $-200,782 | -1.69 % | $147,770 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Jetstream Capital Llc | Institution | 202,200 | New Holding | 202,200 | 100 % | $5,598,918 | $5,503,884 | $-95,034 | -1.69 % | $-95,034 | | | | | | News Article | History of Jetstream Capital Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 73,557 | Added More | 24,507 | 49.96 % | $2,036,793 | $2,002,222 | $-34,572 | -1.69 % | $-11,518 | | | | | | News Article | History of Kbc Group Nv Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kinetics Asset Management Inc | Institution | 21,000 | New Holding | 21,000 | 100 % | $581,490 | $571,620 | $-9,870 | -1.69 % | $-9,870 | | | | | | News Article | History of Kinetics Asset Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 36,130 | Sold Some | -35,346 | -49.45 % | $1,000,440 | $983,459 | $-16,981 | -1.69 % | $16,613 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 160,717 | Added More | 36,574 | 29.46 % | $4,450,254 | $4,374,717 | $-75,537 | -1.69 % | $-17,190 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Oshaughnessy Asset Management Llc | Institution | 47,698 | Added More | 43,750 | 1108.15 % | $1,320,758 | $1,298,340 | $-22,418 | -1.69 % | $-20,563 | | | | | | News Article | History of Oshaughnessy Asset Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 52,801 | Sold Some | -26,085 | -33.06 % | $1,462,060 | $1,437,243 | $-24,816 | -1.69 % | $12,260 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 292,914 | Sold Some | -198,681 | -40.41 % | $8,110,789 | $7,973,119 | $-137,670 | -1.69 % | $93,380 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Palisade Capital Management Llc | Institution | 232,900 | New Holding | 232,900 | 100 % | $6,449,001 | $6,339,538 | $-109,463 | -1.69 % | $-109,463 | | | | | | News Article | History of Palisade Capital Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Placemark Investments Inc | Institution | 12,985 | New Holding | 12,985 | 100 % | $359,555 | $353,452 | $-6,103 | -1.69 % | $-6,103 | | | | | | News Article | History of Placemark Investments Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Principal Financial Group Inc | Institution | 1,397,237 | Sold Some | -167,000 | -10.67 % | $38,689,493 | $38,032,791 | $-656,701 | -1.69 % | $78,490 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Redstone Investment Management Lp | Institution | 34,535 | New Holding | 34,535 | 100 % | $956,274 | $940,043 | $-16,231 | -1.69 % | $-16,231 | | | | | | News Article | History of Redstone Investment Management Lp Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 171,417 | Sold Some | -263,158 | -60.55 % | $4,746,537 | $4,665,971 | $-80,566 | -1.69 % | $123,684 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rs Investment Management Co Llc | Institution | 416,180 | New Holding | 416,180 | 100 % | $11,524,024 | $11,328,420 | $-195,605 | -1.69 % | $-195,605 | | | | | | News Article | History of Rs Investment Management Co Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | 40,293 | New Holding | 40,293 | 100 % | $1,115,713 | $1,096,775 | $-18,938 | -1.69 % | $-18,938 | | | | | | News Article | History of Russell Frank Co Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | San Francisco Sentry Investment Group | Institution | 2,000 | New Holding | 2,000 | 100 % | $55,380 | $54,440 | $-940 | -1.69 % | $-940 | | | | | | News Article | History of San Francisco Sentry Investment Group Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sands Capital Management Llc | Institution | 96,100 | New Holding | 96,100 | 100 % | $2,661,009 | $2,615,842 | $-45,167 | -1.69 % | $-45,167 | | | | | | News Article | History of Sands Capital Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Santa Fe Partners Llc | Institution | 13,462 | New Holding | 13,462 | 100 % | $372,763 | $366,436 | $-6,327 | -1.69 % | $-6,327 | | | | | | News Article | History of Santa Fe Partners Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Ssi Investment Management Inc | Institution | 15,885 | New Holding | 15,885 | 100 % | $439,856 | $432,390 | $-7,466 | -1.69 % | $-7,466 | | | | | | News Article | History of Ssi Investment Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Stafford Asset Management Llc | No Data | | Sold All | -21,780 | -100 % | | | | -1.69 % | $10,237 | | | | | | News Article | History of Stafford Asset Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Strategic Investment Management | Institution | | Sold All | -47,551 | -100 % | | | | -1.69 % | $22,349 | | | | | | News Article | History of Strategic Investment Management Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suffolk Capital Management Llc | Institution | 69,200 | New Holding | 69,200 | 100 % | $1,916,148 | $1,883,624 | $-32,524 | -1.69 % | $-32,524 | | | | | | News Article | History of Suffolk Capital Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suntrust Banks Inc | Institution | 90,195 | Added More | 76,259 | 547.20 % | $2,497,500 | $2,455,108 | $-42,392 | -1.69 % | $-35,842 | | | | | | News Article | History of Suntrust Banks Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 23,510 | Sold Some | -901,555 | -97.45 % | $650,992 | $639,942 | $-11,050 | -1.69 % | $423,731 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | | Sold All | -684,209 | -100 % | | | | -1.69 % | $321,578 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Tewksbury Capital Management Ltd | Institution | | Sold All | -20,477 | -100 % | | | | -1.69 % | $9,624 | | | | | | News Article | History of Tewksbury Capital Management Ltd Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | 233,474 | Sold Some | -379,190 | -61.89 % | $6,464,895 | $6,355,162 | $-109,733 | -1.69 % | $178,219 | | | | | | News Article | History of United Services Automobile Association Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Veritable L P | Institution | 15,131 | New Holding | 15,131 | 100 % | $418,977 | $411,866 | $-7,112 | -1.69 % | $-7,112 | | | | | | News Article | History of Veritable L P Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 79,400 | New Holding | 79,400 | 100 % | $2,198,586 | $2,161,268 | $-37,318 | -1.69 % | $-37,318 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Wm Advisors Inc | Institution | | Sold All | -30,000 | -100 % | | | | -1.69 % | $14,100 | | | | | | News Article | History of Wm Advisors Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | World Asset Management Inc | Institution | 20,909 | Added More | 3,927 | 23.12 % | $578,970 | $569,143 | $-9,827 | -1.69 % | $-1,846 | | | | | | News Article | History of World Asset Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Alphabet Management Llc | No Data | 28,681 | New Holding | 28,681 | 100 % | $818,843 | $780,697 | $-38,146 | -4.65 % | $-38,146 | | | | | | News Article | History of Alphabet Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 227,198 | New Holding | 227,198 | 100 % | $6,486,503 | $6,184,330 | $-302,173 | -4.65 % | $-302,173 | | | | | | News Article | History of American Century Companies Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Baker Bros Advisors Llc | Institution | 1,637,988 | New Holding | 1,637,988 | 100 % | $46,764,557 | $44,586,033 | $-2,178,524 | -4.65 % | $-2,178,524 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 2,981,814 | Added More | 2,882,186 | 2892.94 % | $85,130,790 | $81,164,977 | $-3,965,813 | -4.65 % | $-3,833,307 | | | | | | News Article | History of Citigroup Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Clarivest Asset Management Llc | Institution | 261,169 | Sold Some | -394,831 | -60.18 % | $7,456,375 | $7,109,020 | $-347,355 | -4.65 % | $525,125 | | | | | | News Article | History of Clarivest Asset Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 39,296 | Added More | 21,117 | 116.16 % | $1,121,901 | $1,069,637 | $-52,264 | -4.65 % | $-28,086 | | | | | | News Article | History of Comerica Bank Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | D L Carlson Investment Group Inc | Institution | 24,000 | New Holding | 24,000 | 100 % | $685,200 | $653,280 | $-31,920 | -4.65 % | $-31,920 | | | | | | News Article | History of D L Carlson Investment Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 3,516 | No Change | 0 | 0 % | $100,382 | $95,706 | $-4,676 | -4.65 % | $0 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Highbridge Capital Management Llc | Institution | | Sold All | -119,468 | -100 % | | | | -4.65 % | $158,892 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ig Investment Management Ltd | Institution | 1,324 | Sold Some | -1,376 | -50.96 % | $37,800 | $36,039 | $-1,761 | -4.65 % | $1,830 | | | | | | News Article | History of Ig Investment Management Ltd Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Imc-Chicago Llc | No Data | 32,835 | New Holding | 32,835 | 100 % | $937,439 | $893,769 | $-43,671 | -4.65 % | $-43,671 | | | | | | News Article | History of Imc-Chicago Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 560,464 | Added More | 277,851 | 98.31 % | $16,001,247 | $15,255,830 | $-745,417 | -4.65 % | $-369,542 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 2,890,005 | Added More | 171,647 | 6.31 % | $82,509,643 | $78,665,936 | $-3,843,707 | -4.65 % | $-228,291 | | | | | | News Article | History of Ubs Ag Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | William Harris Investors Inc | Institution | 25,000 | New Holding | 25,000 | 100 % | $713,750 | $680,500 | $-33,250 | -4.65 % | $-33,250 | | | | | | News Article | History of William Harris Investors Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 1,349,767 | New Holding | 1,349,767 | 100 % | $38,198,406 | $36,740,658 | $-1,457,748 | -3.81 % | $-1,457,748 | | | | | | News Article | History of Federated Investors Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-09 | 2009-09-30 | N-Q | Forum Funds - Adams Harkness Small Cap Growth Fund | Small-Cap Growth | 7,785 | New Holding | 7,785 | 100 % | $220,316 | $211,908 | $-8,408 | -3.81 % | $-8,408 | | | | | | News Article | History of Forum Funds - Adams Harkness Small Cap Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Goldman Jay G | Institution | 200,000 | New Holding | 200,000 | 100 % | $5,660,000 | $5,444,000 | $-216,000 | -3.81 % | $-216,000 | | | | | | News Article | History of Goldman Jay G Ownership Of Human Genome Sciences Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Massachusetts Financial Services Co | Institution | 956,090 | New Holding | 956,090 | 100 % | $27,057,347 | $26,024,770 | $-1,032,577 | -3.81 % | $-1,032,577 | | | | | | News Article | History of Massachusetts Financial Services Co Ownership Of Human Genome Sciences Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Mckinley Capital Management Inc | Institution | 317,030 | New Holding | 317,030 | 100 % | $8,971,949 | $8,629,557 | $-342,392 | -3.81 % | $-342,392 | | | | | | News Article | History of Mckinley Capital Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 33,100 | New Holding | 33,100 | 100 % | $936,730 | $900,982 | $-35,748 | -3.81 % | $-35,748 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | State Of Wisconsin Investment Board | Institution | | Sold All | -450,000 | -100 % | | | | -3.81 % | $486,000 | | | | | | News Article | History of State Of Wisconsin Investment Board Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Blair William And Co | Institution | 16,750 | Sold Some | -3,300 | -16.45 % | $462,133 | $455,935 | $-6,198 | -1.34 % | $1,221 | | | | | | News Article | History of Blair William And Co Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Genworth Financial Inc | Institution | 80 | New Holding | 80 | 100 % | $2,207 | $2,178 | $-30 | -1.34 % | $-30 | | | | | | News Article | History of Genworth Financial Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | 553,316 | New Holding | 553,316 | 100 % | $15,265,988 | $15,061,262 | $-204,727 | -1.34 % | $-204,727 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metlife Securities Inc | Institution | 500 | New Holding | 500 | 100 % | $13,795 | $13,610 | $-185 | -1.34 % | $-185 | | | | | | News Article | History of Metlife Securities Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 149,191 | Added More | 23,926 | 19.10 % | $4,116,180 | $4,060,979 | $-55,201 | -1.34 % | $-8,853 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 6,500 | Sold Some | -6,394 | -49.58 % | $179,335 | $176,930 | $-2,405 | -1.34 % | $2,366 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 17,600 | Added More | 12,500 | 245.09 % | $485,584 | $479,072 | $-6,512 | -1.34 % | $-4,625 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tcw Group Inc | Institution | 1,556,898 | New Holding | 1,556,898 | 100 % | $42,954,816 | $42,378,764 | $-576,052 | -1.34 % | $-576,052 | | | | | | News Article | History of Tcw Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 285,129 | Added More | 154,394 | 118.09 % | $7,866,709 | $7,761,211 | $-105,498 | -1.34 % | $-57,126 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 1,047,207 | Added More | 246,323 | 30.75 % | $28,892,441 | $28,504,975 | $-387,467 | -1.34 % | $-91,140 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Unionbancal Corp | Institution | 25,000 | Sold Some | -95,000 | -79.16 % | $689,750 | $680,500 | $-9,250 | -1.34 % | $35,150 | | | | | | News Article | History of Unionbancal Corp Ownership Of Human Genome Sciences Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | 8,800 | New Holding | 8,800 | 100 % | $242,616 | $239,536 | $-3,080 | -1.26 % | $-3,080 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Human Genome Sciences Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 46,796 | Added More | 25,677 | 121.58 % | $1,290,166 | $1,273,787 | $-16,379 | -1.26 % | $-8,987 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Human Genome Sciences Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 26,652 | New Holding | 26,652 | 100 % | $734,796 | $725,467 | $-9,328 | -1.26 % | $-9,328 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 46,304 | Sold Some | -7,038 | -13.19 % | $1,276,601 | $1,260,395 | $-16,206 | -1.26 % | $2,463 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Roosevelt Investment Group Inc | Institution | 1,488,128 | New Holding | 1,488,128 | 100 % | $41,027,689 | $40,506,844 | $-520,845 | -1.26 % | $-520,845 | | | | | | News Article | History of Roosevelt Investment Group Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Geewax Plus Partners Llc | Institution | | Sold All | -91,426 | -100 % | | | | 2.79 % | $-67,655 | | | | | | News Article | History of Geewax Plus Partners Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 153,000 | Added More | 19,000 | 14.17 % | $4,051,440 | $4,164,660 | $113,220 | 2.79 % | $14,060 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Human Genome Sciences Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Alliancebernstein Portfolios - Alliancebernstein Growth Fund | Multi-Cap Growth | 228,400 | New Holding | 228,400 | 100 % | $6,048,032 | $6,217,048 | $169,016 | 2.79 % | $169,016 | | | | | | News Article | History of Alliancebernstein Portfolios - Alliancebernstein Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Enhanced Small Cap Fund | Small-Cap Core | | Sold All | -12,600 | -100 % | | | | 2.79 % | $-9,324 | | | | | | News Article | History of Ssga Funds - Ssga Enhanced Small Cap Fund Ownership Of Human Genome Sciences Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Small Cap Fund | Small-Cap Core | 2,550 | New Holding | 2,550 | 100 % | $67,524 | $69,411 | $1,887 | 2.79 % | $1,887 | | | | | | News Article | History of Ssga Funds - Ssga Small Cap Fund Ownership Of Human Genome Sciences Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | M And T Bank Corp | Institution | 140,325 | Added More | 6,525 | 4.87 % | $3,938,923 | $3,819,647 | $-119,276 | -3.02 % | $-5,546 | | | | | | News Article | History of M And T Bank Corp Ownership Of Human Genome Sciences Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Management Llc | Institution | 13,910 | New Holding | 13,910 | 100 % | $390,454 | $378,630 | $-11,824 | -3.02 % | $-11,824 | | | | | | News Article | History of Turner Investment Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 926,695 | New Holding | 926,695 | 100 % | $26,012,329 | $25,224,638 | $-787,691 | -3.02 % | $-787,691 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Citizens Bank Wealth Management Na | Institution | 167 | New Holding | 167 | 100 % | $4,222 | $4,546 | $324 | 7.67 % | $324 | | | | | | News Article | History of Citizens Bank Wealth Management Na Ownership Of Human Genome Sciences Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Emerald Advisers Inc | Institution | 347,981 | New Holding | 347,981 | 100 % | $8,796,960 | $9,472,043 | $675,083 | 7.67 % | $675,083 | | | | | | News Article | History of Emerald Advisers Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Emerald Mutual Fund Advisers Trust | Institution | 150,311 | New Holding | 150,311 | 100 % | $3,799,862 | $4,091,465 | $291,603 | 7.67 % | $291,603 | | | | | | News Article | History of Emerald Mutual Fund Advisers Trust Ownership Of Human Genome Sciences Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Quest Investment Management Inc | Institution | 23,920 | New Holding | 23,920 | 100 % | $604,698 | $651,102 | $46,405 | 7.67 % | $46,405 | | | | | | News Article | History of Quest Investment Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Health Care Portfolio | Health/Biotech | 52,600 | New Holding | 52,600 | 100 % | $1,329,728 | $1,431,772 | $102,044 | 7.67 % | $102,044 | | | | | | News Article | History of Fidelity Select Portfolios - Health Care Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Medical Delivery Portfolio | Health/Biotech | 5,400 | New Holding | 5,400 | 100 % | $136,512 | $146,988 | $10,476 | 7.67 % | $10,476 | | | | | | News Article | History of Fidelity Select Portfolios - Medical Delivery Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 15,000 | New Holding | 15,000 | 100 % | $379,200 | $408,300 | $29,100 | 7.67 % | $29,100 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 1,517,459 | Added More | 1,017,593 | 203.57 % | $38,361,364 | $41,305,234 | $2,943,870 | 7.67 % | $1,974,130 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | | Sold All | -219,063 | -100 % | | | | 45.63 % | $-1,868,607 | | | | | | News Article | History of Oxford Asset Management Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Balanced Fund | Mixed-Asset Target Allocation Moderate | 80,000 | New Holding | 80,000 | 100 % | $1,495,200 | $2,177,600 | $682,400 | 45.63 % | $682,400 | | | | | | News Article | History of Fidelity Advisor Series I - Balanced Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Growth Opportunities Fund | Large-Cap Core | 630,200 | New Holding | 630,200 | 100 % | $11,778,438 | $17,154,044 | $5,375,606 | 45.63 % | $5,375,606 | | | | | | News Article | History of Fidelity Advisor Series I - Growth Opportunities Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 6,425 | No Compare | | | $120,083 | $174,889 | $54,805 | 45.63 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-CSRS | Fidelity Commonwealth Trust Ii - Fidelity Small Cap Enhanced Index Fund | Small-Cap Core | 11,500 | New Holding | 11,500 | 100 % | $214,935 | $313,030 | $98,095 | 45.63 % | $98,095 | | | | | | News Article | History of Fidelity Commonwealth Trust Ii - Fidelity Small Cap Enhanced Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund | Multi-Cap Growth | 512,200 | New Holding | 512,200 | 100 % | $9,573,018 | $13,942,084 | $4,369,066 | 45.63 % | $4,369,066 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund | Multi-Cap Growth | | Sold All | -12,755,010 | -100 % | | | | 45.63 % | $-108,800,235 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Securities Fund - Agressive Growth Fund | Global Small/Mid-Cap Growth | 8,700 | New Holding | 8,700 | 100 % | $162,603 | $236,814 | $74,211 | 45.63 % | $74,211 | | | | | | News Article | History of Fidelity Securities Fund - Agressive Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Jennison Sector Funds Inc - Jennison Health Sciences Fund | Health/Biotech | 394,300 | New Holding | 394,300 | 100 % | $7,369,467 | $10,732,846 | $3,363,379 | 45.63 % | $3,363,379 | | | | | | News Article | History of Jennison Sector Funds Inc - Jennison Health Sciences Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Lord Abbett Research Fund Inc - Growth Opportunities Fund | Mid-Cap Growth | 60,700 | New Holding | 60,700 | 100 % | $1,134,483 | $1,652,254 | $517,771 | 45.63 % | $517,771 | | | | | | News Article | History of Lord Abbett Research Fund Inc - Growth Opportunities Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Managers Amg Funds - Essex Growth Fund | Multi-Cap Growth | 5,528 | New Holding | 5,528 | 100 % | $103,318 | $150,472 | $47,154 | 45.63 % | $47,154 | | | | | | News Article | History of Managers Amg Funds - Essex Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 1,279,471 | Sold Some | -89,107 | -6.51 % | $25,551,036 | $34,827,201 | $9,276,165 | 36.30 % | $-646,026 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Human Genome Sciences Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Unified Series Trust - Leeb Focus Fund | Specialty & Misc | 72,812 | New Holding | 72,812 | 100 % | $1,454,056 | $1,981,943 | $527,887 | 36.30 % | $527,887 | | | | | | News Article | History of Unified Series Trust - Leeb Focus Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -6,900 | -100 % | | | | 36.30 % | $-50,025 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -2,900 | -100 % | | | | 36.30 % | $-21,025 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Health Sciences Fund | Health/Biotech | 75,500 | New Holding | 75,500 | 100 % | $1,507,735 | $2,055,110 | $547,375 | 36.30 % | $547,375 | | | | | | News Article | History of Valic Co I - Health Sciences Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 131,776 | New Holding | 131,776 | 100 % | $2,631,567 | $3,586,943 | $955,376 | 36.30 % | $955,376 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Carl Domino Inc | Institution | 60,000 | No Change | 0 | 0 % | $1,080,600 | $1,633,200 | $552,600 | 51.13 % | $0 | | | | | | News Article | History of Carl Domino Inc Ownership Of Human Genome Sciences Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Quotient Investors Llc | No Data | 11,300 | New Holding | 11,300 | 100 % | $203,513 | $307,586 | $104,073 | 51.13 % | $104,073 | | | | | | News Article | History of Quotient Investors Llc Ownership Of Human Genome Sciences Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Sandy Spring Bank | No Data | 880 | No Change | 0 | 0 % | $15,849 | $23,954 | $8,105 | 51.13 % | $0 | | | | | | News Article | History of Sandy Spring Bank Ownership Of Human Genome Sciences Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Brazos Mutual Funds - Brazos Small Cap Portfolio | Small-Cap Growth | 9,300 | New Holding | 9,300 | 100 % | $167,493 | $253,146 | $85,653 | 51.13 % | $85,653 | | | | | | News Article | History of Brazos Mutual Funds - Brazos Small Cap Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Dws Securities Trust - Dws Health Care Fund | Health/Biotech | 130,500 | No Change | 0 | 0 % | $2,350,305 | $3,552,210 | $1,201,905 | 51.13 % | $0 | | | | | | News Article | History of Dws Securities Trust - Dws Health Care Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Essex Investment Management Co Llc | Institution | 131,534 | New Holding | 131,534 | 100 % | $2,526,768 | $3,580,355 | $1,053,587 | 41.69 % | $1,053,587 | | | | | | News Article | History of Essex Investment Management Co Llc Ownership Of Human Genome Sciences Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Schroder Investment Management Group | Institution | 20,000 | New Holding | 20,000 | 100 % | $388,600 | $544,400 | $155,800 | 40.09 % | $155,800 | | | | | | News Article | History of Schroder Investment Management Group Ownership Of Human Genome Sciences Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Texan Capital Management | No Data | 10,100 | New Holding | 10,100 | 100 % | $196,243 | $274,922 | $78,679 | 40.09 % | $78,679 | | | | | | News Article | History of Texan Capital Management Ownership Of Human Genome Sciences Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | | Sold All | -73 | -100 % | | | | 40.09 % | $-569 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of Human Genome Sciences Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 29,500 | Sold Some | -550,489 | -94.91 % | $573,185 | $802,990 | $229,805 | 40.09 % | $-4,288,309 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Human Genome Sciences Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Columbus Circle Investors | Institution | 616,919 | New Holding | 616,919 | 100 % | $12,110,120 | $16,792,535 | $4,682,415 | 38.66 % | $4,682,415 | | | | | | News Article | History of Columbus Circle Investors Ownership Of Human Genome Sciences Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Pinnacle Associates Ltd | Institution | | Sold All | -15,000 | -100 % | | | | 38.66 % | $-113,850 | | | | | | News Article | History of Pinnacle Associates Ltd Ownership Of Human Genome Sciences Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 199,800 | New Holding | 199,800 | 100 % | $4,077,918 | $5,438,556 | $1,360,638 | 33.36 % | $1,360,638 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 71,804 | Added More | 25,081 | 53.68 % | $1,465,520 | $1,954,505 | $488,985 | 33.36 % | $170,802 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Human Genome Sciences Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 92,300 | Added More | 47,387 | 105.50 % | $1,883,843 | $2,512,406 | $628,563 | 33.36 % | $322,705 | | | | | | News Article | History of Blackrock Inc Ownership Of Human Genome Sciences Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 450,633 | Added More | 134,639 | 42.60 % | $9,197,420 | $12,266,230 | $3,068,811 | 33.36 % | $916,892 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-10-22 | 2009-08-31 | N-Q | Mfs Series Trust Ii - Mfs Emerging Growth Fund | Emerging Markets | 183,470 | New Holding | 183,470 | 100 % | $3,744,623 | $4,994,053 | $1,249,431 | 33.36 % | $1,249,431 | | | | | | News Article | History of Mfs Series Trust Ii - Mfs Emerging Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 1,947,953 | Added More | 1,316,879 | 208.67 % | $37,166,943 | $53,023,281 | $15,856,337 | 42.66 % | $10,719,395 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Human Genome Sciences Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 243,732 | Added More | 57,180 | 30.65 % | $4,650,407 | $6,634,385 | $1,983,978 | 42.66 % | $465,445 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Human Genome Sciences Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 155,500 | Added More | 76,000 | 95.59 % | $3,105,335 | $4,232,710 | $1,127,375 | 36.30 % | $551,000 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Human Genome Sciences Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Weisel Thomas Partners Asset Management Llc | Institution | 15,318 | New Holding | 15,318 | 100 % | $305,900 | $416,956 | $111,056 | 36.30 % | $111,056 | | | | | | News Article | History of Weisel Thomas Partners Asset Management Llc Ownership Of Human Genome Sciences Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 125,300 | Added More | 100,000 | 395.25 % | $2,615,011 | $3,410,666 | $795,655 | 30.42 % | $635,000 | | | | | | News Article | History of Strs Ohio Ownership Of Human Genome Sciences Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Shufro Rose And Co Llc | Institution | | Sold All | -12,000 | -100 % | | | | 36.37 % | $-87,120 | | | | | | News Article | History of Shufro Rose And Co Llc Ownership Of Human Genome Sciences Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | 18,349 | Sold Some | -17,750 | -49.17 % | $356,338 | $499,460 | $143,122 | 40.16 % | $-138,450 | | | | | | News Article | History of Harris Financial Corp Ownership Of Human Genome Sciences Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 212,601 | Sold Some | -42,164 | -16.55 % | $4,128,711 | $5,786,999 | $1,658,288 | 40.16 % | $-328,879 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Human Genome Sciences Inc |
| 2009-10-15 | 2007-03-31 | 13F-HR/A | Northwestern Mutual Life Insurance Co | Institution | | Sold All | -275 | -100 % | | | | 40.16 % | $-2,145 | | | | | | News Article | History of Northwestern Mutual Life Insurance Co Ownership Of Human Genome Sciences Inc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Financial Architects Inc | Institution | 300 | New Holding | 300 | 100 % | $5,523 | $8,166 | $2,643 | 47.85 % | $2,643 | | | | | | News Article | History of Financial Architects Inc Ownership Of Human Genome Sciences Inc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Galaxy Capital Trading Ltd | Institution | 29,000 | New Holding | 29,000 | 100 % | $533,890 | $789,380 | $255,490 | 47.85 % | $255,490 | | | | | | News Article | History of Galaxy Capital Trading Ltd Ownership Of Human Genome Sciences Inc |
| 2009-10-09 | 2009-09-30 | 13F-HR | Brown Capital Management Inc | Institution | 377,410 | Sold Some | -872,522 | -69.80 % | $6,982,085 | $10,273,100 | $3,291,015 | 47.13 % | $-7,608,392 | | | | | | News Article | History of Brown Capital Management Inc Ownership Of Human Genome Sciences Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | Lord Abbett Developing Growth Fund Inc New - Lord Abbett Developing Growth Fund Inc New | Small-Cap Growth | 389,873 | New Holding | 389,873 | 100 % | $7,212,651 | $10,612,343 | $3,399,693 | 47.13 % | $3,399,693 | | | | | | News Article | History of Lord Abbett Developing Growth Fund Inc New - Lord Abbett Developing Growth Fund Inc New Ownership Of Human Genome Sciences Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | Lord Abbett Large Cap Growth Fund - Lord Abbett Large Cap Growth Fund | Large-Cap Growth | 67,152 | New Holding | 67,152 | 100 % | $1,242,312 | $1,827,877 | $585,565 | 47.13 % | $585,565 | | | | | | News Article | History of Lord Abbett Large Cap Growth Fund - Lord Abbett Large Cap Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | World Funds Trust - Commonwealth Small Cap Fund | No Data | 300 | New Holding | 300 | 100 % | $5,550 | $8,166 | $2,616 | 47.13 % | $2,616 | | | | | | News Article | History of World Funds Trust - Commonwealth Small Cap Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 223,890 | Added More | 18,366 | 8.93 % | $4,074,798 | $6,094,286 | $2,019,488 | 49.56 % | $165,661 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Human Genome Sciences Inc |
| 2009-10-07 | 2009-09-30 | 13F-HR | Oak Associates Ltd | Institution | | Sold All | -20,000 | -100 % | | | | 43.56 % | $-165,200 | | | | | | News Article | History of Oak Associates Ltd Ownership Of Human Genome Sciences Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 144,616 | Added More | 123,115 | 572.60 % | $2,741,919 | $3,936,448 | $1,194,528 | 43.56 % | $1,016,930 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund | Health/Biotech | 23,800 | New Holding | 23,800 | 100 % | $451,248 | $647,836 | $196,588 | 43.56 % | $196,588 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-07 | 2009-07-31 | N-CSRS | Fidelity Devonshire Trust - Fidelity Series All-Sector Equity Fund | No Data | 531,500 | New Holding | 531,500 | 100 % | $10,077,240 | $14,467,430 | $4,390,190 | 43.56 % | $4,390,190 | | | | | | News Article | History of Fidelity Devonshire Trust - Fidelity Series All-Sector Equity Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Bull Profund | Large-Cap Core | 5,300 | Added More | 2,625 | 98.13 % | $100,488 | $144,266 | $43,778 | 43.56 % | $21,683 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Human Genome Sciences Inc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Bb And T Corp | Institution | 13,299 | New Holding | 13,299 | 100 % | $254,410 | $361,999 | $107,589 | 42.28 % | $107,589 | | | | | | News Article | History of Bb And T Corp Ownership Of Human Genome Sciences Inc |
| 2009-10-02 | 2009-09-30 | 13F-HR | Cornerstone Investment Partners Llc | Institution | | Sold All | -10,000 | -100 % | | | | 49.56 % | $-90,200 | | | | | | News Article | History of Cornerstone Investment Partners Llc Ownership Of Human Genome Sciences Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 163,600 | New Holding | 163,600 | 100 % | $2,977,520 | $4,453,192 | $1,475,672 | 49.56 % | $1,475,672 | | | | | | News Article | History of Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Mid Cap Growth Fund Inc - Alliancebernstein Mid Cap Growth Fund Inc | Mid-Cap Growth | 149,400 | New Holding | 149,400 | 100 % | $2,719,080 | $4,066,668 | $1,347,588 | 49.56 % | $1,347,588 | | | | | | News Article | History of Alliancebernstein Mid Cap Growth Fund Inc - Alliancebernstein Mid Cap Growth Fund Inc Ownership Of Human Genome Sciences Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 2,900 | New Holding | 2,900 | 100 % | $52,780 | $78,938 | $26,158 | 49.56 % | $26,158 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Small Cap Stock Fund | Small-Cap Core | 267,374 | Sold Some | -341,690 | -56.10 % | $4,866,207 | $7,277,920 | $2,411,713 | 49.56 % | $-3,082,044 | | | | | | News Article | History of Usaa Mutual Funds Trust - Small Cap Stock Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - New Opportunities Fund | Small-Cap Growth | 44,911 | New Holding | 44,911 | 100 % | $845,674 | $1,222,477 | $376,803 | 44.55 % | $376,803 | | | | | | News Article | History of American Century Mutual Funds Inc - New Opportunities Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - New Opportunities Ii | Small-Cap Growth | 151,421 | New Holding | 151,421 | 100 % | $2,851,257 | $4,121,680 | $1,270,422 | 44.55 % | $1,270,422 | | | | | | News Article | History of American Century Mutual Funds Inc - New Opportunities Ii Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 137,001 | Added More | 62,880 | 84.83 % | $2,579,729 | $3,729,167 | $1,149,438 | 44.55 % | $527,563 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 2,200 | Added More | 1,000 | 83.33 % | $41,426 | $59,884 | $18,458 | 44.55 % | $8,390 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Va Small Value Portfolio | Small-Cap Value | 197,019 | No Change | 0 | 0 % | $3,709,868 | $5,362,857 | $1,652,989 | 44.55 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Va Small Value Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc - Small Cap Growth Opportunities Fund | Small-Cap Growth | 42,632 | New Holding | 42,632 | 100 % | $802,761 | $1,160,443 | $357,682 | 44.55 % | $357,682 | | | | | | News Article | History of First American Investment Funds Inc - Small Cap Growth Opportunities Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Small Growth Index Fund | Small-Cap Growth | | Sold All | -36,806 | -100 % | | | | 44.55 % | $-308,802 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Small Growth Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Fund | Large-Cap Growth | 657,907 | New Holding | 657,907 | 100 % | $12,388,389 | $17,908,229 | $5,519,840 | 44.55 % | $5,519,840 | | | | | | News Article | History of Janus Investment Fund - Janus Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 895 | No Change | 0 | 0 % | $16,853 | $24,362 | $7,509 | 44.55 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Oppenheimer Quest For Value Funds - Oppenheimer Quest Opportunity Value Fund | Flexible Portfolio | | Sold All | -876,515 | -100 % | | | | 44.55 % | $-7,353,961 | | | | | | News Article | History of Oppenheimer Quest For Value Funds - Oppenheimer Quest Opportunity Value Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Russell Investment Co - International Fund | International Multi-Cap Core | | Sold All | -28,775 | -100 % | | | | 44.55 % | $-241,422 | | | | | | News Article | History of Russell Investment Co - International Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Fbr Funds - Fbr Pegasus Small Cap Fund | Small-Cap Growth | 1,550 | New Holding | 1,550 | 100 % | $29,295 | $42,191 | $12,896 | 44.02 % | $12,896 | | | | | | News Article | History of Fbr Funds - Fbr Pegasus Small Cap Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Fbr Funds - Fbr Small Cap Fund | Small-Cap Growth | 800 | New Holding | 800 | 100 % | $15,120 | $21,776 | $6,656 | 44.02 % | $6,656 | | | | | | News Article | History of Fbr Funds - Fbr Small Cap Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -14,730 | -100 % | | | | 44.02 % | $-122,554 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -26,600 | -100 % | | | | 44.02 % | $-221,312 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 5,000 | No Change | 0 | 0 % | $94,500 | $136,100 | $41,600 | 44.02 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Market Portfolio | Specialty & Misc | 1,497,895 | New Holding | 1,497,895 | 100 % | $28,310,216 | $40,772,702 | $12,462,486 | 44.02 % | $12,462,486 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Market Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 2,280 | New Holding | 2,280 | 100 % | $43,092 | $62,062 | $18,970 | 44.02 % | $18,970 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio | No Data | 3,075 | Added More | 185 | 6.40 % | $58,118 | $83,702 | $25,584 | 44.02 % | $1,539 | | | | | | News Article | History of Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mfs Government Limited Maturity Fund Ma - Mfs Diversified Target Return Fund | No Data | 2,860 | New Holding | 2,860 | 100 % | $52,109 | $77,849 | $25,740 | 49.39 % | $25,740 | | | | | | News Article | History of Mfs Government Limited Maturity Fund Ma - Mfs Diversified Target Return Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Multi Cap Growth Fund | Multi-Cap Core | 2,475 | New Holding | 2,475 | 100 % | $45,095 | $67,370 | $22,275 | 49.39 % | $22,275 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Multi Cap Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb Small Cap Growth Fund | Small-Cap Growth | 126,000 | New Holding | 126,000 | 100 % | $2,295,720 | $3,429,720 | $1,134,000 | 49.39 % | $1,134,000 | | | | | | News Article | History of Mtb Group Of Funds - Mtb Small Cap Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 49,050 | Sold Some | -99,889 | -67.06 % | $893,691 | $1,335,141 | $441,450 | 49.39 % | $-899,001 | | | | | | News Article | History of Kbc Group Nv Ownership Of Human Genome Sciences Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | | Sold All | -49,700 | -100 % | | | | 48.98 % | $-444,815 | | | | | | News Article | History of Credit Agricole S A Ownership Of Human Genome Sciences Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Premier Opportunity Funds - Health Care Fund | Health/Biotech | 17,630 | New Holding | 17,630 | 100 % | $341,846 | $479,889 | $138,043 | 40.38 % | $138,043 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds - Health Care Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 2,910 | New Holding | 2,910 | 100 % | $56,309 | $79,210 | $22,902 | 40.67 % | $22,902 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Human Genome Sciences Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 7,546,453 | Added More | 393,738 | 5.50 % | $145,042,827 | $205,414,451 | $60,371,624 | 41.62 % | $3,149,904 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Human Genome Sciences Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 7,207,103 | Added More | 54,388 | 0.76 % | $138,520,520 | $196,177,344 | $57,656,824 | 41.62 % | $435,104 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Human Genome Sciences Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 3,636 | Sold Some | -717 | -16.47 % | $69,957 | $98,972 | $29,015 | 41.47 % | $-5,722 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 76,176 | Sold Some | -25,620 | -25.16 % | $1,465,626 | $2,073,511 | $607,884 | 41.47 % | $-204,448 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Global Allocation Portfolio | Global Flex Port | | Sold All | -36,100 | -100 % | | | | 40.96 % | $-285,551 | | | | | | News Article | History of Advanced Series Trust - Ast Global Allocation Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 75,600 | Added More | 58,700 | 347.33 % | $1,459,836 | $2,057,832 | $597,996 | 40.96 % | $464,317 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio | Small-Cap Value | | Sold All | -140,700 | -100 % | | | | 40.96 % | $-1,112,937 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 93,900 | No Change | 0 | 0 % | $1,813,209 | $2,555,958 | $742,749 | 40.96 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 24,230 | New Holding | 24,230 | 100 % | $467,881 | $659,541 | $191,659 | 40.96 % | $191,659 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 208,580 | Sold Some | -193,620 | -48.14 % | $4,027,680 | $5,677,548 | $1,649,868 | 40.96 % | $-1,531,534 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Small Cap Core Fund | Small-Cap Core | 1 | New Holding | 1 | 100 % | $19 | $27 | $8 | 40.96 % | $8 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Small Cap Core Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Core Bond Fund | Multi-Cap Core | 1 | New Holding | 1 | 100 % | $19 | $27 | $8 | 40.96 % | $8 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Core Bond Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Mid Cap Growth Equity Ii Fund | Mid-Cap Growth | 376,000 | No Change | 0 | 0 % | $7,260,560 | $10,234,720 | $2,974,160 | 40.96 % | $0 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Mid Cap Growth Equity Ii Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Bull Profund | Large-Cap Core | 2,675 | New Holding | 2,675 | 100 % | $51,654 | $72,814 | $21,159 | 40.96 % | $21,159 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Aim Small Cap Growth Fund | No Data | | Sold All | -4,898 | -100 % | | | | 40.96 % | $-38,743 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Aim Small Cap Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 8,790 | Sold Some | -22,210 | -71.64 % | $169,735 | $239,264 | $69,529 | 40.96 % | $-175,681 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Anchor Series Trust - Asset Allocation Portfolio | Specialty & Misc | | Sold All | -30,000 | -100 % | | | | 49.88 % | $-271,800 | | | | | | News Article | History of Anchor Series Trust - Asset Allocation Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund - Mml Mid Cap Growth Fund | Mid-Cap Growth | 87,000 | No Change | 0 | 0 % | $1,579,920 | $2,368,140 | $788,220 | 49.88 % | $0 | | | | | | News Article | History of Mml Series Investment Fund - Mml Mid Cap Growth Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 8,280 | Sold Some | -10,900 | -56.83 % | $150,365 | $225,382 | $75,017 | 49.88 % | $-98,754 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Human Genome Sciences Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 2,471 | No Compare | | | $44,873 | $67,261 | $22,387 | 49.88 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -28,391 | -100 % | | | | 49.88 % | $-257,222 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Human Genome Sciences Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Lazard Mid Cap Portfolio | Mid-Cap Core | 356,000 | Added More | 34,000 | 10.55 % | $6,215,760 | $9,690,320 | $3,474,560 | 55.89 % | $331,840 | | | | | | News Article | History of Met Investors Series Trust - Lazard Mid Cap Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Metaim Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -371,647 | -100 % | | | | 55.89 % | $-3,627,275 | | | | | | News Article | History of Met Investors Series Trust - Metaim Small Cap Growth Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 1,655,276 | Sold Some | -1,181,558 | -41.65 % | $30,705,370 | $45,056,613 | $14,351,243 | 46.73 % | $-10,244,108 | | | | | | News Article | History of Amvescap Plc Ownership Of Human Genome Sciences Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fidelity International Ltd | Institution | 11,710 | New Holding | 11,710 | 100 % | $217,221 | $318,746 | $101,526 | 46.73 % | $101,526 | | | | | | News Article | History of Fidelity International Ltd Ownership Of Human Genome Sciences Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 5,716,797 | Sold Some | -1,667,680 | -22.58 % | $106,046,584 | $155,611,214 | $49,564,630 | 46.73 % | $-14,458,786 | | | | | | News Article | History of Fmr Corp Ownership Of Human Genome Sciences Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Biotechnology Fund | Health/Biotech | 487,959 | Added More | 162,600 | 49.97 % | $9,051,639 | $13,282,244 | $4,230,605 | 46.73 % | $1,409,742 | | | | | | News Article | History of Rydex Series Funds - Biotechnology Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Nottingham Investment Trust Ii - The Brown Capital Management Small Company Fund | Small-Cap Core | 303,495 | No Change | 0 | 0 % | $5,997,061 | $8,261,134 | $2,264,073 | 37.75 % | $0 | | | | | | News Article | History of Nottingham Investment Trust Ii - The Brown Capital Management Small Company Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 1,379 | No Change | 0 | 0 % | $27,249 | $37,536 | $10,287 | 37.75 % | $0 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Occ Value | Large-Cap Value | 516,510 | Sold Some | -762,850 | -59.62 % | $10,226,898 | $14,059,402 | $3,832,504 | 37.47 % | $-5,660,347 | | | | | | News Article | History of Allianz Funds - Occ Value Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 649,058 | Sold Some | -31,320 | -4.60 % | $12,851,348 | $17,667,359 | $4,816,010 | 37.47 % | $-232,394 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 961,130 | Added More | 857,334 | 825.97 % | $19,030,374 | $26,161,959 | $7,131,585 | 37.47 % | $6,361,418 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 1,636,982 | Sold Some | -48,548 | -2.88 % | $32,412,244 | $44,558,650 | $12,146,406 | 37.47 % | $-360,226 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Value Index Fund | Multi-Cap Value | | Sold All | -972,531 | -100 % | | | | 37.47 % | $-7,216,180 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Value Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 8,453 | Added More | 7,426 | 723.07 % | $167,369 | $230,091 | $62,721 | 37.47 % | $55,101 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 37,038 | Added More | 2,160 | 6.19 % | $733,352 | $1,008,174 | $274,822 | 37.47 % | $16,027 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Value Index Fund | Multi-Cap Value | | Sold All | -7,989 | -100 % | | | | 37.47 % | $-59,278 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Value Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 17,469 | Added More | 13,122 | 301.86 % | $345,886 | $475,506 | $129,620 | 37.47 % | $97,365 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Human Genome Sciences Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Global Life Sciences Portfolio | Science & Tech | 19,743 | Sold Some | -7,198 | -26.71 % | $374,327 | $537,404 | $163,077 | 43.56 % | $-59,455 | | | | | | News Article | History of Janus Aspen Series - Global Life Sciences Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Oppenheimer Balanced Fund - Oppenheimer Balanced Fund | Mixed-Asset Target Allocation Moderate | | Sold All | -539,000 | -100 % | | | | 43.56 % | $-4,452,140 | | | | | | News Article | History of Oppenheimer Balanced Fund - Oppenheimer Balanced Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 91,852 | Added More | 14,892 | 19.35 % | $1,741,514 | $2,500,211 | $758,698 | 43.56 % | $123,008 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -4,527 | -100 % | | | | 43.56 % | $-37,393 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 828,552 | New Holding | 828,552 | 100 % | $15,709,346 | $22,553,185 | $6,843,840 | 43.56 % | $6,843,840 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 1,047,766 | New Holding | 1,047,766 | 100 % | $19,865,643 | $28,520,191 | $8,654,547 | 43.56 % | $8,654,547 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 1,935,283 | New Holding | 1,935,283 | 100 % | $36,692,966 | $52,678,403 | $15,985,438 | 43.56 % | $15,985,438 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 81,363 | Added More | 32,000 | 64.82 % | $1,542,642 | $2,214,701 | $672,058 | 43.56 % | $264,320 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 49,363 | No Change | 0 | 0 % | $935,922 | $1,343,661 | $407,738 | 43.56 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Human Genome Sciences Inc |
| 2009-08-24 | 2009-06-30 | 13F-HR | Advent Capital Management | Institution | 5,000 | New Holding | 5,000 | 100 % | $85,900 | $136,100 | $50,200 | 58.44 % | $50,200 | | | | | | News Article | History of Advent Capital Management Ownership Of Human Genome Sciences Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Balanced Fundva | Flexible Portfolio | 256,420 | New Holding | 256,420 | 100 % | $4,405,296 | $6,979,752 | $2,574,457 | 58.44 % | $2,574,457 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Balanced Fundva Ownership Of Human Genome Sciences Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 43,700 | New Holding | 43,700 | 100 % | $750,766 | $1,189,514 | $438,748 | 58.44 % | $438,748 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Human Genome Sciences Inc |
| 2009-08-21 | 2009-06-30 | N-CSRS | Dws Variable Series I - Dws Health Care Vip | Health/Biotech | 45,300 | Sold Some | -2,900 | -6.01 % | $745,185 | $1,233,066 | $487,881 | 65.47 % | $-31,233 | | | | | | News Article | History of Dws Variable Series I - Dws Health Care Vip Ownership Of Human Genome Sciences Inc |
| 2009-08-21 | 2009-06-30 | N-CSR | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 186,160 | New Holding | 186,160 | 100 % | $3,062,332 | $5,067,275 | $2,004,943 | 65.47 % | $2,004,943 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Human Genome Sciences Inc |
RSS feed for HGSI